Oramed Pharmaceuticals (ORMP) Tax Rate (2016 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Tax Rate came in at 22.51% in Q1 2026, up 3079.0% YoY from 0.71% in Q1 2025, and up 119.35% on a QoQ basis from 116.34% in Q4 2025.
Oramed Pharmaceuticals (ORMP) Tax Rate (2016 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 6 years of Tax Rate data on file, last reported at 22.51% in Q1 2026.
- Quarterly Tax Rate rose 3079.0% year-over-year to 22.51% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.09% (up 2346.0% YoY) and the FY2025 annual result came in at 0.16%, up 2016.0% from the prior year.
- Tax Rate grew to 22.51% in Q1 2026, from 116.34% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 22.51% in Q1 2026 to a low of 116.34% in Q4 2025.
- A 4-year average of 7.95% and a median of 1.18% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2025 — Tax Rate sank 11209 bps — and 2026, when it surged 3079 bps.
- Tracing ORMP's Tax Rate over 4 years: stood at 1.63% in 2022, then sank by 361 bps to 4.25% in 2024, then plunged by 2636 bps to 116.34% in 2025, then soared by 119 bps to 22.51% in 2026.
- The last three Tax Rate figures came in at 22.51% (Q1 2026), 116.34% (Q4 2025), and 18.61% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 198.23 Mn | 198.23 Mn | - | 23.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.06% |
| Jun 30, 2026 | 23.06% |
| Jun 30, 2026 | 23.06% |
| Mar 31, 2026 | 22.51% |
| Mar 31, 2026 | 22.51% |
| Mar 31, 2026 | 22.51% |
| Dec 31, 2025 | -116.34% |
| Dec 31, 2025 | -116.34% |
| Dec 31, 2025 | -116.34% |
| Sep 30, 2025 | 18.61% |
| Sep 30, 2025 | 18.61% |
| Sep 30, 2025 | 18.61% |
| Jun 30, 2025 | -0.96% |
| Jun 30, 2025 | -0.96% |
| Jun 30, 2025 | -0.96% |
| Mar 31, 2025 | -8.27% |
| Mar 31, 2025 | -8.27% |
| Mar 31, 2025 | -8.27% |
| Dec 31, 2024 | -4.25% |
| Dec 31, 2024 | -4.25% |